Mariner Independent Advisor Network’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Mariner Independent Advisor Network's ARKG Position: Q3 2022 in Review
Mariner Independent Advisor Network reduced its ARK Genomic Revolution ETF (ARKG) stake by 5.4% in Q3 2022, selling an estimated $122K and leaving 58,525 shares worth $1.92M. The position accounts for 0.08% of the portfolio, ranked #243.
Mariner Independent Advisor Network first reported a position in ARKG in Q4 2017 and has held it in 18 quarters since. The position peaked at $17.4M in Q1 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.
- Mariner Independent Advisor Network held 58,525 shares of ARK Genomic Revolution ETF worth $1.92M as of Q3 2022.
- Mariner Independent Advisor Network sold 3,311 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $122K.
- ARK Genomic Revolution ETF made up 0.08% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #243 holding.
- Mariner Independent Advisor Network first reported a position in ARK Genomic Revolution ETF in Q4 2017 and has held it in 18 quarters since.
- Mariner Independent Advisor Network's ARK Genomic Revolution ETF position peaked at $17.4M in Q1 2021.
- 311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.
Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.